ROSA Total Knee Investigational Testing Authorization Study (NCT03970629) | Clinical Trial Compass
TerminatedNot Applicable
ROSA Total Knee Investigational Testing Authorization Study
Stopped: Challenging enrollment due to COVID-19.
Canada19 participantsStarted 2019-06-20
Plain-language summary
This is a prospective, single-center clinical study designed to facilitate the collection and evaluation of workflow efficiency, patient pain and function, and adverse event data. This clinical study will include Persona Total Knee components using the ROSA Total Knee Robotic System or conventional instrumentation.
Who can participate
Age range18 Years – 70 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Patient is a minimum of 18 years of age
✓. Pre-op component positioning and sizing plan prior to surgery
✓. Independent of study participation, patient is a candidate for primary TKA using the commercially available Persona knee components implanted in accordance with product labeling
✓. Patient has participated in this study-related Informed Consent process
✓. Patient is willing and able to provide written Informed Consent by signing and dating the IRB or EC approved Informed Consent form
✓. Patient is willing and able to complete scheduled study procedures and follow-up evaluations
Exclusion criteria
✕. Patient is currently participating in any other surgical intervention studies or pain management studies
✕. Patient has underwent contralateral UKA or TKA within the last 18 months
✕. Hip pathology with significant bone loss (e.g. avascular necrosis of the femoral head with collapse, severe dysplasia of the femoral head or the acetabulum)
✕. Hip pathology severely limiting range of motion (e.g. arthrodesis, severe contracture, chronic severe dislocation)
✕. Patient is pregnant or considered a member of a protected population (e.g., prisoner, mentally incompetent, etc.)